“…EPC are involved in vessel development and regeneration, being recruited from the bone-marrow to the peripheral blood, displaying immunopositivity for CD34, CD45, CD133, VEGFR2, c-kit, and, presumably existing as hematopoietic cells with pro-angiogenic activity in vitro and in vivo (Richardson and Yoder, 2011; Yoder, 2012). In adults, there are two origins of EPC: (i) hematopoietic origin (EPC derived from bone marrow multipotent hemangioblasts [VEGFR2(+)VE-cadherin(+)CD45(−) and mesenchymal stem cells (MSC) (CD73(+)CD90(+)CD105(+)CD34(−)CD45(−)]; (ii) and non-hematopoietic origin (EPC found at the sites of extensive angiogenesis but demonstrating no signs of hematopoietic origin, being, probably, derived from tissue multipotent cells) (Chao and Hirschi, 2010; Leeper et al, 2010; Boxall and Jones, 2012). …”